Advanced search
Start date
Betweenand


Cooperation in R&D in the pharmaceutical industry: Technological and clinical trial networks in oncology

Full text
Author(s):
Lanchoti Fiori, Giovana Maria ; Basso, Fernanda Gisele ; Porto, Geciane Silveira
Total Authors: 3
Document type: Journal article
Source: TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE; v. 176, p. 15-pg., 2022-03-01.
Abstract

Research and development (R&D) in pharmaceutical industries is essential for the development of new drugs and partnerships are responsible to achieve and maintain competitiveness in the market. Cancer represents a global health problem and new oncology drugs are essential. This study verified how cooperation takes place aimed at the invention (patents) and development (clinical trials - CT) of treatments with the primary target being oncology. Using social network analyses to generate technological discoveries, cooperation networks using patents, and a CT development collaboration network, the 526 CT and 294 patents were analyzed in collaboration between universities, hospitals, companies, and other institutions. The results show the evolution of patents from chemical synthetic processes to biomarkers and immunological checkpoint inhibitors. The associations of the CT network tend to have more partnerships than the patent network, which indicates greater trust and the need for complementary expertise. This study indicates that during the R&D stages of new oncology drugs, organizations search for actors of different types, as experts are needed for each stage. Although companies are predominant in both networks, research institutes play a central role in this connection. This study can be applied for researchers, universities, institutes and companies interested in R&D and in the other therapeutic areas. (AU)

FAPESP's process: 17/25364-6 - Mapping of Cooperation Networks and Technological Trends in Biotechnology Patents through Social Network Analysis
Grantee:Geciane Silveira Porto
Support Opportunities: Regular Research Grants